Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Bevacizumab and Metabolomics, with related work in Mycoplasma pneumoniae, Heart failure, Streptococcus pneumoniae. Notable publications include 'Efficacy and tolerability of bevacizumab in patients with severe Covid-19', 'Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease', and 'Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study'.